アロステリック調節因子 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "アロステリック調節因子" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

5^th place

19^th place

1guidetopharmacology.org

low place

low place

6^th place

146^th place

archive.org

Lehninger Principles of Biochemistry (5th ed.). W.H. Freeman. (2008). pp. 162. ISBN 978-0-7167-7108-1

doi.org

“International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology”. Pharmacological Reviews 55 (4): 597–606. (December 2003). doi:10.1124/pr.55.4.4. PMID 14657418.
Pharmacology in drug discovery and development: understanding drug response (2nd ed.). Academic Press. (2017). pp. 102–119. doi:10.1016/B978-0-12-803752-2.00005-3. ISBN 978-0-12-803752-2
“Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors”. Journal of Neuroscience 25 (39): 9027–9036. (2005-09-28). doi:10.1523/JNEUROSCI.2567-05.2005. ISSN 0270-6474. PMC 6725607. PMID 16192394.
Chemokine receptor oligomerization and allostery. 115. Academic Press. (2013). 4–5. doi:10.1016/B978-0-12-394587-7.00009-9. ISBN 978-0-12-394587-7. PMC 4072031. PMID 23415099
“Allosteric modulation of 7 transmembrane spanning receptors: theory, practice, and opportunities for CNS drug discovery”. Journal of Medicinal Chemistry 55 (4): 1445–64. (February 2012). doi:10.1021/jm201139r. PMC 3349997. PMID 22148748.
“5 Allosteric Ligands”. Molecular Pharmacology 93 (5): 504–514. (May 2018). doi:10.1124/mol.117.111518. PMID 29514854.
Biased signaling in physiology, pharmacology and therapeutics. Elsevier. (2014). pp. 187–189. doi:10.1016/B978-0-12-411460-9.00006-9. ISBN 9780124114609
Principles of bone biology (4th ed.). Elsevier. (2019). pp. 542. doi:10.1016/B978-0-12-814841-9.00023-3. ISBN 9780128148419
“Allosteric Modulator Discovery: From Serendipity to Structure-Based Design”. Journal of Medicinal Chemistry 62 (14): 6405–6421. (July 2019). doi:10.1021/acs.jmedchem.8b01749. PMID 30817889.
“Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice”. Journal of Medicinal Chemistry 62 (1): 159–173. (2019-01-10). doi:10.1021/acs.jmedchem.7b01492. ISSN 1520-4804. PMID 29587480.
“Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations”. Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2011 Meeting of the Society for Neuroscience) 82 (8): 915–930. (2011-10-15). doi:10.1016/j.bcp.2011.05.001. ISSN 0006-2952. PMC 3162128. PMID 21575610.
“mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning”. Neuropsychopharmacology 34 (9): 2057–2071. (2009). doi:10.1038/npp.2009.30. ISSN 1740-634X. PMC 2884290. PMID 19295507.
“Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders”. Neuropsychotherapeutics. Advances in Pharmacology. 86. (2019). pp. 273–305. doi:10.1016/bs.apha.2019.06.001. ISBN 9780128166680. ISSN 1557-8925. PMID 31378255

guidetopharmacology.org

“International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology”. Pharmacological Reviews 55 (4): 597–606. (December 2003). doi:10.1124/pr.55.4.4. PMID 14657418.

nih.gov

pubmed.ncbi.nlm.nih.gov

“International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology”. Pharmacological Reviews 55 (4): 597–606. (December 2003). doi:10.1124/pr.55.4.4. PMID 14657418.
“Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors”. Journal of Neuroscience 25 (39): 9027–9036. (2005-09-28). doi:10.1523/JNEUROSCI.2567-05.2005. ISSN 0270-6474. PMC 6725607. PMID 16192394.
Chemokine receptor oligomerization and allostery. 115. Academic Press. (2013). 4–5. doi:10.1016/B978-0-12-394587-7.00009-9. ISBN 978-0-12-394587-7. PMC 4072031. PMID 23415099
“Allosteric modulation of 7 transmembrane spanning receptors: theory, practice, and opportunities for CNS drug discovery”. Journal of Medicinal Chemistry 55 (4): 1445–64. (February 2012). doi:10.1021/jm201139r. PMC 3349997. PMID 22148748.
“5 Allosteric Ligands”. Molecular Pharmacology 93 (5): 504–514. (May 2018). doi:10.1124/mol.117.111518. PMID 29514854.
“Allosteric Modulator Discovery: From Serendipity to Structure-Based Design”. Journal of Medicinal Chemistry 62 (14): 6405–6421. (July 2019). doi:10.1021/acs.jmedchem.8b01749. PMID 30817889.
“Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice”. Journal of Medicinal Chemistry 62 (1): 159–173. (2019-01-10). doi:10.1021/acs.jmedchem.7b01492. ISSN 1520-4804. PMID 29587480.
“Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations”. Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2011 Meeting of the Society for Neuroscience) 82 (8): 915–930. (2011-10-15). doi:10.1016/j.bcp.2011.05.001. ISSN 0006-2952. PMC 3162128. PMID 21575610.
“mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning”. Neuropsychopharmacology 34 (9): 2057–2071. (2009). doi:10.1038/npp.2009.30. ISSN 1740-634X. PMC 2884290. PMID 19295507.
“Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders”. Neuropsychotherapeutics. Advances in Pharmacology. 86. (2019). pp. 273–305. doi:10.1016/bs.apha.2019.06.001. ISBN 9780128166680. ISSN 1557-8925. PMID 31378255

pmc.ncbi.nlm.nih.gov

“Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors”. Journal of Neuroscience 25 (39): 9027–9036. (2005-09-28). doi:10.1523/JNEUROSCI.2567-05.2005. ISSN 0270-6474. PMC 6725607. PMID 16192394.
Chemokine receptor oligomerization and allostery. 115. Academic Press. (2013). 4–5. doi:10.1016/B978-0-12-394587-7.00009-9. ISBN 978-0-12-394587-7. PMC 4072031. PMID 23415099
“Allosteric modulation of 7 transmembrane spanning receptors: theory, practice, and opportunities for CNS drug discovery”. Journal of Medicinal Chemistry 55 (4): 1445–64. (February 2012). doi:10.1021/jm201139r. PMC 3349997. PMID 22148748.
“Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations”. Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2011 Meeting of the Society for Neuroscience) 82 (8): 915–930. (2011-10-15). doi:10.1016/j.bcp.2011.05.001. ISSN 0006-2952. PMC 3162128. PMID 21575610.
“mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning”. Neuropsychopharmacology 34 (9): 2057–2071. (2009). doi:10.1038/npp.2009.30. ISSN 1740-634X. PMC 2884290. PMID 19295507.

ncbi.nlm.nih.gov

“Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors”. Journal of Neuroscience 25 (39): 9027–9036. (2005-09-28). doi:10.1523/JNEUROSCI.2567-05.2005. ISSN 0270-6474. PMC 6725607. PMID 16192394.
“Allosteric modulation of 7 transmembrane spanning receptors: theory, practice, and opportunities for CNS drug discovery”. Journal of Medicinal Chemistry 55 (4): 1445–64. (February 2012). doi:10.1021/jm201139r. PMC 3349997. PMID 22148748.
“Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations”. Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2011 Meeting of the Society for Neuroscience) 82 (8): 915–930. (2011-10-15). doi:10.1016/j.bcp.2011.05.001. ISSN 0006-2952. PMC 3162128. PMID 21575610.
“mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning”. Neuropsychopharmacology 34 (9): 2057–2071. (2009). doi:10.1038/npp.2009.30. ISSN 1740-634X. PMC 2884290. PMID 19295507.

worldcat.org

search.worldcat.org

“Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors”. Journal of Neuroscience 25 (39): 9027–9036. (2005-09-28). doi:10.1523/JNEUROSCI.2567-05.2005. ISSN 0270-6474. PMC 6725607. PMID 16192394.
“Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice”. Journal of Medicinal Chemistry 62 (1): 159–173. (2019-01-10). doi:10.1021/acs.jmedchem.7b01492. ISSN 1520-4804. PMID 29587480.
“Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations”. Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2011 Meeting of the Society for Neuroscience) 82 (8): 915–930. (2011-10-15). doi:10.1016/j.bcp.2011.05.001. ISSN 0006-2952. PMC 3162128. PMID 21575610.
“mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning”. Neuropsychopharmacology 34 (9): 2057–2071. (2009). doi:10.1038/npp.2009.30. ISSN 1740-634X. PMC 2884290. PMID 19295507.
“Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders”. Neuropsychotherapeutics. Advances in Pharmacology. 86. (2019). pp. 273–305. doi:10.1016/bs.apha.2019.06.001. ISBN 9780128166680. ISSN 1557-8925. PMID 31378255